Rare (Orphan) disease: tension between government support of developing new therapies and reimbursement processes? Perspectives from EU-5 (Germany, UK, France, Spain and Italy), Central East Europe, USA and Canada [Panel issue]
HomePublicationsRare (Orphan) disease: tension between government support of developing new therapies and reimbursement processes? Perspectives from EU-5 (Germany, UK, France, Spain and Italy), Central East Europe, USA and Canada [Panel issue]
Rare (Orphan) disease: tension between government support of developing new therapies and reimbursement processes? Perspectives from EU-5 (Germany, UK, France, Spain and Italy), Central East Europe, USA and Canada [Panel issue]
2010 ISPOR 13th Annual European Meeting, November 6-9, 2010, Prague, Czech Republic
Pashos, C. | Toumi, M. | Kalo, Z. | Lorand, E. |
Volume: ,
Issue: ,
Pages: ,
